Market cap
$37.397 M
$2.33 +0.87%
Close of 7 Aug 2026
Revenue
$16.9M
#3054 by revenue
Earnings
-$22.7M
Loss-making
Shares outstanding
16,050,320
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Biotechnology: Pharmaceutical Preparations — ranked by market cap
All 501 →Where these numbers come from
Share counts and financials for Veru are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.